BOLTON SECURITIES CORPORATION’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.49M Sell
3,994
-198
-5% -$116K 0.09% 227
2026
Q2
$2.22M Buy
4,192
+605
+17% +$279K 0.08% 257
2026
Q1
$1.72M Buy
3,587
+269
+8% +$138K 0.08% 264
2025
Q4
$1.86M Buy
3,318
+1,327
+67% +$753K 0.09% 254
2025
Q3
$1.02M Buy
1,991
+459
+30% +$200K 0.05% 362
2025
Q2
$481K Sell
1,532
-65
-4% -$19.5K 0.03% 507
2025
Q1
$487K Buy
+1,597
New +$537K 0.03% 488

Other funds holding MEDP

BOLTON SECURITIES CORPORATION's MEDP Position: Q3 2026 in Review

BOLTON SECURITIES CORPORATION reduced its Medpace (MEDP) stake by 4.7% in Q3 2026, selling an estimated $116K and leaving 3,994 shares worth $2.49M. The position accounts for 0.09% of the portfolio, ranked #227.

BOLTON SECURITIES CORPORATION first reported a position in MEDP in Q1 2025 and has held it in 7 quarters since. 619 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

  • BOLTON SECURITIES CORPORATION held 3,994 shares of Medpace worth $2.49M as of Q3 2026.
  • BOLTON SECURITIES CORPORATION sold 198 Medpace shares in Q3 2026, an estimated $116K.
  • Medpace made up 0.09% of BOLTON SECURITIES CORPORATION's portfolio in Q3 2026, its #227 holding.
  • BOLTON SECURITIES CORPORATION first reported a position in Medpace in Q1 2025 and has held it in 7 quarters since.
  • 619 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q3 2026, filed 12 Nov 2026.